I'm so proud of this group! You girls did a tremendous job in this review: Therapeutic Targets in Innate Immunity to Tackle Alzheimer's Disease @Cells_MDPI@Alzheimer_eV@HertieNeuroSci@dfg_public https://t.co/R6MT54q3kf
Wissenschaftliche Erkenntnisse im Kampf gegen ALS - Das #ukbonn & das @DZNE_de laden am Freitag, 18. August, Fachleute, Betroffene & Interessierte zu einem Informationstag rund um die fortschreitende Nervenlähmung ein.
https://t.co/jBfyOLNjGb
Super excited to share a new paper from our lab! Microglia engulf synapses in disease, but which synapses are targeted and whether these are beneficial or detrimental has been unclear. Here we show that microglia engulf synapses to resolve neuronal hyperactivity. Microglia [1/3]
Two days ago we had the huge privilege to watch Nora Guthrie and Ken Casey from the Dropkick Murphy’s discuss Woody Guthrie’s impact on Punkrock and Huntington’s disease. A real gem … check it out. It’s currently only on Insta, but we’ll change that ! https://t.co/6yhA0OjZuA
Congratulation to our medical doctorate student @punsan, all the ALS Team Bonn and @als_docBonn on our latest biomarker study. The good old-fashioned cardiac marker, CK-MB, holds considerable potential as a source of information for diagnosing ALS. https://t.co/EinT3zhYNR
Enjoy this latest biomarker work led by @CastroGomezSerg uncovering the unexpected information gained from understanding standard „cardiac“ muscle markers in ALS. Clearly this only the beginning.
https://t.co/4KuMstYCAG #mdpiijms via @IJMS_MDPI@MDPIOpenAccess @ukbonn @DZNE_en
Bitter Pill… highly recommended read in the current @NewYorker on the vexing complexities of drug approval in ALS. Don’t miss it, if you are in the field 👨🏼🏫. Excellent work by Gideon Lewis Kraus 👌🏻 https://t.co/cTjfXqw2ys
Lab’s 1st paper out: SPP1 immune-immune crosstalk at the synapse @NatureNeuro! @SebastiaanDeSc2 perfectly summarizes below so won’t add but just this very happy photo of us after 🥂🥂🍾🥳 ! 1st paper esp post Covid is extra meaningful- so proud & grateful for @SebastiaanDeSc2 ..
Heute Fortbildung im Dysphagiezentrum Köln zum Thema neurogene Schluckstörungen. Toll, dass es hier die Weiterbildung zum Fachtherapeuten Dysphagie gibt.
🤓 @ Köln-Innenstadt https://t.co/ETftUph1Dt
This is clearly a very special case (young patient, defined mutation, treated early), but shows the enormous potential treating ALS Awesome story, Anna and family!
This is what a cure is going to look like for real.
#goanna#als#hopeforals#annathefighter
This is an excellent and measured YouTube clip of a (genetic) @ALS case that is making headline news in Germany. Everyone in the ALS community and beyond should take note. A young FUS ALS patient is making an absolutely remarkable recovery …
https://t.co/QsFOCa6pot
…after being treated by first-rate neurologist Neil Shneider @ColumbiaUniversity and then wonderful Markus Weber of @KantonsspitalSG with an ASO compound developed by amazing @Ionis Pharmaceuticals, Inc.